Gregory P Conley

Title: Gregory P. Conley: Innovator in Plasma Kallikrein Research

Introduction

Gregory P. Conley is a prominent inventor based in Arlington, MA (US), known for his significant contributions to the field of biomedical research. He holds a total of 8 patents, showcasing his innovative approach to understanding and manipulating the plasma kallikrein system.

Latest Patents

Among his latest patents are groundbreaking methods and assays for determining the activation level of the plasma kallikrein (pKal) system. These innovations are crucial for assessing the activity of pKal modulators on the pKal system. Additionally, he has developed bispecific antibodies that target both plasma kallikrein and Factor XII. These antibodies have potential applications in treating diseases associated with the contact system, such as hereditary angioedema and thrombosis.

Career Highlights

Gregory has worked with notable companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Dyax Corporation. His work in these organizations has allowed him to advance his research and contribute to the development of new therapeutic strategies.

Collaborations

Throughout his career, Gregory has collaborated with esteemed colleagues, including Andrew Nixon and Daniel J. Sexton. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Gregory P. Conley is a distinguished inventor whose work in plasma kallikrein research has the potential to transform therapeutic approaches to various diseases. His contributions continue to influence the field and inspire future innovations.